GNH USA

Europe — EMA

Muconasal Spray (Tramazoline Hydrochloride Monohydrate)

GNH USA supplies Muconasal (Tramazoline Hydrochloride), a nasal decongestant for nasal congestion and rhinitis. Request a quote for global supply worldwide.

Request sourcing

1
Pack/s

What is Tramazoline Hydrochloride Monohydrate?

Tramazoline hydrochloride, the active ingredient in Muconasal, is a Alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion and rhinitis in adults and children.

GNH USA supplies Muconasal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tramazoline Hydrochloride Monohydrate used for?

Tramazoline hydrochloride is an alpha‑adrenergic agonist used to relieve nasal congestion associated with various upper‑respiratory conditions.

- Nasal congestion: reduces swelling of the nasal mucosa and improves airflow. - Acute rhinitis: alleviates blockage caused by inflammation of the nasal passages. - Seasonal allergic rhinitis: provides temporary relief of nasal stuffiness during allergen exposure.

What are the side effects of Tramazoline Hydrochloride Monohydrate?

Common Side Effects: - Nasal dryness: mild irritation or crusting inside the nostrils. - Sneezing: transient increase in sneezing episodes after administration. - Epistaxis: occasional nosebleeds, usually mild. - Headache: brief headache following use. - Taste disturbance: altered sense of taste or metallic taste. - Local irritation: burning or stinging sensation.

Serious or Rare Side Effects: - Hypertension: elevated blood pressure, especially with overuse. - Tachycardia: rapid heart rate that may require monitoring. - Arrhythmia: irregular heart rhythms in susceptible individuals. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Rebound congestion: worsening nasal blockage after prolonged use (rhinitis medicamentosa).

What precautions apply to Tramazoline Hydrochloride Monohydrate?

Before using Muconasal, consider the following precautions: - Children under 6 years: avoid use unless directed by a healthcare professional. - Prolonged use: limit to no more than three consecutive days to prevent rebound congestion. - Hypertension: monitor blood pressure closely if you have high blood pressure. - Cardiovascular disease: use with caution in patients with heart disease or arrhythmias. - Pregnancy and lactation: safety not established; consult a physician before use. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

What does Tramazoline Hydrochloride Monohydrate interact with?

Tramazoline may interact with other medicines as follows:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause excessive vasoconstriction and hypertensive crisis. - Other sympathomimetic agents (e.g., phenylephrine): additive vasoconstrictive effects can increase cardiovascular risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia caused by the nasal spray. - Antihypertensive drugs: monitor blood pressure for potential elevation. - Combination nasal decongestants: avoid using multiple decongestants simultaneously to reduce risk of systemic side effects.

Frequently asked questions

What is Muconasal Spray used for?+
Muconasal Spray contains tramazoline hydrochloride and is indicated for the temporary relief of nasal congestion and blockage associated with acute rhinitis, seasonal allergic rhinitis, and other upper‑respiratory conditions that cause swollen nasal passages.
How does Tramazoline hydrochloride work?+
Tramazoline hydrochloride selectively stimulates alpha‑adrenergic receptors on the blood vessels of the nasal mucosa. This activation causes vasoconstriction, which reduces mucosal swelling and opens the airway, providing rapid decongestion.
What is the usual dose of Muconasal Spray?+
The exact dosing regimen is determined by the prescriber. In general, adults may be advised to administer one to two sprays per nostril, not exceeding three consecutive days of use, to avoid rebound congestion.
Is Muconasal safe in pregnancy or breastfeeding?+
Safety data for tramazoline hydrochloride during pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks with their healthcare provider before using the product.
How do I order Muconasal from GNH USA?+
To request Muconasal, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Muconasal compare with other nasal decongestants?+
Muconasal’s active ingredient, tramazoline, belongs to the alpha‑adrenergic agonist class, similar to oxymetazoline and phenylephrine. All provide rapid vasoconstriction, but tramazoline is noted for a slightly shorter duration of action, which may reduce the risk of prolonged rebound congestion when used as directed.
How should Muconasal be stored and handled?+
Store Muconasal at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.
How is Muconasal administered?+
Tilt the head slightly forward, insert the nozzle into one nostril, and press down to release the recommended number of sprays. Repeat in the other nostril if advised. Avoid blowing the nose immediately after application to allow the medication to act.
What are the most serious risks to watch for with Muconasal?+
Serious adverse events, though rare, include significant hypertension, tachycardia, arrhythmias, severe allergic reactions such as anaphylaxis, and rebound nasal congestion after prolonged use. Any sudden increase in blood pressure, rapid heartbeat, or severe nasal bleeding should prompt immediate medical evaluation.
Who should not use Muconasal?+
Muconasal should be avoided in children younger than six years, patients with uncontrolled hypertension, severe coronary artery disease, known hypersensitivity to tramazoline or any formulation component, and individuals taking monoamine oxidase inhibitors. Consultation with a healthcare professional is essential before use in these populations.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Tramazoline Hydrochloride Monohydrate
Route
Nasal Use
Manufacturer
Opella Healthcare Romania Srl
Origin
EU

Related products